Alpha Tau Medical Ltd.
NASDAQ:DRTSBiotechnology
Healthcare
$12.01 +0.42%
+$0.04 today
- Market cap
- $1.11B
- Beta
- 1.20
- P/E (TTM)
- -15.2
- EPS (TTM)
- -$0.63
52W Low $2.85High $11.62
Volume 0.64M
Average 0.69M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$42.29M
FY 2025 · Annual
Net Income
-$42.63M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 776K | 979K | 1.07M | 1.1M | 1.23M |
| Gross Profit | (776K) | (979K) | (1.07M) | (1.1M) | (1.23M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 11.45M | 20.89M | 26.42M | 27.02M | 30.83M |
| Selling, General & Admin | 2.34M | 11.25M | 9.26M | 7.92M | 10.22M |
| Operating Expenses | 13.79M | 32.14M | 34.61M | 34.94M | 41.06M |
| Depreciation & Amortization | 776K | 979K | 1.07M | 1.1M | 1.23M |
| EBITDA | (13.22M) | (32.74M) | (28.03M) | (30.3M) | (41.06M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (13.79M) | (32.14M) | 35.68M | (36.04M) | (42.29M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 211K | 1.79M | 4.76M | 4.28M | 3.84M |
| Interest Expense | 13.27M | 1.77M | 39K | 344K | 419K |
| Other Income / Expenses | (13.47M) | (1.61M) | 6.54M | 4.3M | (218K) |
| Income Before Tax | (27.26M) | (33.74M) | (29.14M) | (31.74M) | (42.51M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 7K | 20K | 16K | 6K | 121K |
| Net Income | (27.27M) | (33.76M) | (29.16M) | (31.75M) | (42.63M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.67) | (0.53) | (0.42) | (0.45) | (0.53) |
| EPS (Diluted) | (0.67) | (0.53) | (0.42) | (0.45) | (0.53) |
| 40.53M | 63.53M | 69.38M | 69.93M | 80.58M | |
| 40.53M | 63.53M | 69.38M | 69.93M | 80.58M |
DRTS Earnings Waterfall · TTM
NASDAQ:DRTS · Revenue to Net Income
Key Ratios
EPS$-0.67
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-7.5
P/S Ratio0.0
Analysis
$0 of revenue converted into -$56.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.67, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 12, 2026 | |
| 6-K | 6-K filing | Oct 29, 2026 | |
| 6-K | 6-K filing | Oct 22, 2026 | |
| 6-K | 6-K filing | Oct 19, 2026 | |
| 6-K | 6-K filing | Aug 31, 2026 |
How much revenue does DRTS generate?
Alpha Tau Medical Ltd. (DRTS) reported $0.00 of revenue in fiscal 2025.
Is DRTS profitable?
Alpha Tau Medical Ltd. (DRTS) reported -$42.63M of net income.
Continue the stock analysis
Jump to another research area for this company.